NA
NUTX

NewEdge Advisors’s Nutex Health NUTX Stock Holding History

NewEdge Advisors’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,967
Closed -$245K – 4203
2025
Q2 		$245K Buy
+1,967
New +$254K ﹤0.01% 2118
2024
Q4 		– Sell
-401
Closed -$8.7K – 3984
2024
Q3 		$8.7K Buy
+401
New +$5.78K ﹤0.01% 2988

Other funds holding NUTX

TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NewEdge Advisors's NUTX Position: Q3 2025 in Review

NewEdge Advisors sold out of Nutex Health (NUTX) in Q3 2025, closing a stake of 1,967 shares — an estimated $245K sold.

NewEdge Advisors first reported a position in NUTX in Q3 2024 and held it in 2 quarters. The position peaked at $245K in Q2 2025. 95 funds tracked by Wall St. Rank hold NUTX as of Q3 2025.

  • NewEdge Advisors reported no remaining Nutex Health position as of Q3 2025 after selling out during the quarter.
  • NewEdge Advisors sold 1,967 Nutex Health shares in Q3 2025, an estimated $245K.
  • NewEdge Advisors first reported a position in Nutex Health in Q3 2024 and held it in 2 quarters.
  • NewEdge Advisors's Nutex Health position peaked at $245K in Q2 2025.
  • 95 funds tracked by Wall St. Rank held Nutex Health as of Q3 2025.

Based on NewEdge Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.